Related Experiment Video
Updated: Jul 1, 2025

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
Published on: September 11, 2012
Association of microscopic colitis and enteropathy due to olmesartan
Lucía Seoane Blanco1, Brais Fernández Suárez2, María Gómez Rivas2
1Digestivo, Hospital Universitario Lucus Augusti (HULA), España.
Abstract:
We report the case of a patient with severe chronic diarrhea. He was admitted on multiple occasions for this reason, with the cause remaining undetected. After obtaining a detailed medical history and performing several studies, the patient was diagnosed with microscopic colitis and enteropathy due to Olmesartan. In the literature, both diseases appear concurrently only in a few cases. Here we highlight the importance of conducting a comprehensive medical history and maintaining high clinical suspicion to avoid delays in the diagnosis of these uncommon pathologies, as well as unnecessary tests and empirical treatments.
Insights
A patient with chronic diarrhea was diagnosed with microscopic colitis and Olmesartan-induced enteropathy. This rare concurrent diagnosis highlights the need for thorough medical history and clinical suspicion in diagnosing uncommon gastrointestinal conditions.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Chronic diarrhea poses a diagnostic challenge, often requiring extensive investigation.
- Olmesartan, a widely used antihypertensive, is associated with gastrointestinal side effects.
- Microscopic colitis is an inflammatory condition of the colon.
Observation:
- A patient presented with recurrent, severe chronic diarrhea of unknown etiology.
- Despite multiple admissions and investigations, the cause of the diarrhea remained elusive.
- A detailed medical history and further studies were crucial for diagnosis.
Findings:
- The patient was diagnosed with concurrent microscopic colitis and Olmesartan-induced enteropathy.
- This combination of conditions is rarely reported in medical literature.
- Olmesartan was identified as the causative agent for the enteropathy.
Implications:
- Emphasizes the importance of a comprehensive patient history in diagnosing complex gastrointestinal disorders.
- Highlights the need for high clinical suspicion to identify uncommon drug-induced enteropathies.
- Suggests that early diagnosis can prevent unnecessary investigations and treatments for chronic diarrhea.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

